Drug-Drug Interaction (DDI) Studies

Assessing how your drug interacts with other drugs in vivo is a critical step in the drug development process and is essential in ensuring safe and efficacious drug delivery. This assessment is known as a drug-drug interaction (DDI) study and is a regulatory requirement for submissions of investigational new drugs (INDs). With patients frequently taking multiple prescriptions, or even over-the-counter drugs, there has been a rise in serious adverse events caused by two or more drugs interacting with each other. Drug interactions can also reduce the effectiveness of a drug, thus making data collected from these studies even more important to developers when understanding the likelihood of downstream clinical and commercial success.

Learn how an innovative development platform with the unique ability to fully integrate DDI studies accelerate timelines and improve the likelihood of downstream success.